利用循环肿瘤 DNA 监测结直肠癌患者的微小残留病灶。
Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer.
机构信息
University of Kentucky.
出版信息
Clin J Oncol Nurs. 2023 Jul 20;27(4):369-374. doi: 10.1188/23.CJON.369-374.
PMID:37677775
Abstract
The emergence of molecular analysis approaches that use circulating tumor DNA (ctDNA) to measure minimal residual disease is shifting the management of colorectal cancer and many solid tumor cancers. Analysis of ctDNA has sev.
摘要
利用循环肿瘤 DNA（ctDNA）进行微小残留病灶检测的分子分析方法的出现正在改变结直肠癌和许多实体瘤癌症的治疗管理方式。ctDNA 分析具有以下几个方面的优势。
Zotero 插件